Lucid Files Resale Prospectus Supplement
NEWARK, Calif., Feb. 24, 2026 /PRNewswire/ — Lucid Group, Inc. (Nasdaq: LCID), maker of the world’s most advanced electric vehicles, today announced... Read more.
Resideo Announces Fourth Quarter and Full Year 2025 Financial Results and Initiates 2026 Outlook
Record high full year 2025 net revenue of $7.47 billion, up 11% year-over-year; ADI Global Distribution (“ADI”) and Products & Solutions (“P&S”)... Read more.
ClearView successfully implements Equisoft’s cloud-based policy administration system
The implementation of Equisoft/manage policy admin system consolidates ClearView’s in-force portfolios onto a single modern platform, eliminating legacy system... Read more.
Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call
SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ — Docusign (Nasdaq: DOCU) today announced that its fourth quarter fiscal 2026 results will be released on Tuesday,... Read more.
Gen to Present at the Morgan Stanley Technology, Media & Telecom Conference
MOUNTAIN VIEW, Calif., Feb. 24, 2026 /PRNewswire/ — Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, today announced... Read more.
Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results
Full year 2025 revenue of $979.1 million Full year 2025 net income of $136.6 million Full year 2025 net cash provided from operations of $255.8 million Entered into... Read more.
Danaher to Present at TD Cowen Health Care Conference
WASHINGTON, Feb. 24, 2026 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting... Read more.
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved therapies are available for... Read more.
Revolve Group Announces Fourth Quarter and Full Year 2025 Financial Results
LOS ANGELES, Feb. 24, 2026 /PRNewswire/ — Revolve Group, Inc. (NYSE: RVLV), the next-generation fashion retailer for Millennial and Generation Z consumers,... Read more.
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
MENLO PARK, Calif., Feb. 24, 2026 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured,... Read more.